Breztri Aerosphere vs Symbicort
A side-by-side look at two respiratory medications advertised on TV. Informational only — not medical advice.
| US Breztri Aerosphere | US Symbicort | |
|---|---|---|
| Generic name | budesonide/glycopyrrolate/formoterol | budesonide/formoterol |
| Drug class | Inhaled Corticosteroid + LAMA + LABA | ICS/LABA Inhaler |
| Treats | COPD | Asthma, COPD |
| Category | Respiratory | Respiratory |
| Manufacturer | AstraZeneca | AstraZeneca |
| Year approved | 2020 | 2006 |
| FDA warning | No boxed warning | No boxed warning |
| Est. TV ad spend | $120M | $120M |
| Common side effects | Respiratory infections, Thrush, Cough, Headache | Throat irritation, Oral thrush, Hoarseness, Headache |
Breztri Aerosphere
Symbicort
Frequently asked questions
Is Breztri Aerosphere or Symbicort better?
Neither is universally "better." Breztri Aerosphere (budesonide/glycopyrrolate/formoterol) and Symbicort (budesonide/formoterol) are both used for respiratory, but the right choice depends on your medical history, insurance and your doctor's guidance. This comparison is informational only.
What's the difference between Breztri Aerosphere and Symbicort?
Breztri Aerosphere is a Inhaled Corticosteroid + LAMA + LABA made by AstraZeneca, while Symbicort is a ICS/LABA Inhaler made by AstraZeneca. See the table above for a side-by-side breakdown.
Which one spends more on TV ads?
Breztri Aerosphere has the larger estimated TV advertising budget of the two.